Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene

Hepatology

Volumn 53, Issue 2, 2011, Pages 587-595

  Donthamsetty, Shashikiran ^a   Bhave, Vishakha S ^a   Kliment, Corrine S ^a   Bowen, William C ^a   Mars, Wendy M ^a   Bell, Aaron W ^a   Stewart, Rachel E ^a   Orr, Anne ^a   Wu, Chuanyue ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; ANDROSTANE DERIVATIVE; CYCLINE; INTEGRIN LINKED KINASE; INTEGRIN RECEPTOR; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE INDUCTION; HEPATOMEGALY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER HYPERPLASIA; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; CELL CYCLE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; HEPATOCYTES; HEPATOMEGALY; MICE; MICE, KNOCKOUT; ORGAN SIZE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 79251511172     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24040     Document Type: Article

References (32)

1. Blanco-Bose WE, Murphy MJ, Ehninger A, Offner S, Dubey C, Huang W, et al. C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. HEPATOLOGY 2008; 48: 1302-1311.
2. Qatanani M, Moore DD. CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab 2005; 6: 329-339.
3. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 1999; 369: 11-23.
4. Diwan BA, Lubet RA, Ward JM, Hrabie JA, Rice JM. Tumor-promoting and hepatocarcinogenic effects of 1, 4-bis[2-(3, 5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 1992; 13: 1893-1901.
5. Columbano A, Ledda-Columbano GM. Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ 2003; 10( Suppl 1): S19-S21.
6. Ledda-Columbano GM, Pibiri M, Loi R, Perra A, Shinozuka H, Columbano A. Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-bis[2-(3, 5-dichloropyridyloxy)] benzene. Am J Pathol 2000; 156: 91-97.
7. Locker J, Tian J, Carver R, Concas D, Cossu C, Ledda-Columbano GM, et al. A common set of immediate-early response genes in liver regeneration and hyperplasia. HEPATOLOGY 2003; 38: 314-325.
8. Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000; 407: 920-923.
9. Golubovskaya VM, Kweh FA, Cance WG. Focal adhesion kinase and cancer. Histol Histopathol 2009; 24: 503-510.
10. Joshi MB, Ivanov D, Philippova M, Erne P, Resink TJ. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. FASEB J 2007; 21: 3083-3095.
11. Li S, Hua ZC. FAK expression regulation and therapeutic potential. Adv Cancer Res 2008; 101: 45-61.
12. McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 2008; 121: 3121-3132.
13. van Nimwegen MJ, van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 2007; 73: 597-609.
14. Zachary I. Focal adhesion kinase. Int J Biochem Cell Biol 1997; 29: 929-934.
15. Zhao J, Zhang Y, Ithychanda SS, Tu Y, Chen K, Qin J, et al. Migfilin interacts with Src and contributes to cell-matrix adhesion-mediated survival signaling. J Biol Chem 2009; 284: 34308-34320.
16. Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, Yang Y, et al. Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. HEPATOLOGY 2008; 48: 1932-1941.
17. Gkretsi V, Mars WM, Bowen WC, Barua L, Yang Y, Guo L, et al. Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis. HEPATOLOGY 2007; 45: 1025-1034.
18. Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. HEPATOLOGY 2009; 50: 844-851.
19. Donthamsetty S, Bowen W, Mars W, Bhave V, Luo JH, Wu C, et al. Liver-specific ablation of integrin-linked kinase in mice results in enhanced and prolonged cell proliferation and hepatomegaly after phenobarbital administration. Toxicol Sci 2010; 113: 358-366.
20. Terpstra L, Prud'homme J, Arabian A, Takeda S, Karsenty G, Dedhar S, et al. Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes. J Cell Biol 2003; 162: 139-148.
21. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999; 39: 295-312.
22. Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 2008; 20: 638-646.
23. Saucedo LJ, Edgar BA. Filling out the Hippo pathway. Nat Rev Mol Cell Biol 2007; 8: 613-621.
24. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6: 635-645.
25. Wang X, Kiyokawa H, Dennewitz MB, Costa RH. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A 2002; 99: 16881-16886.
26. Michalopoulos GK, Bowen WC, Mule K, Luo J. HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr 2003; 11: 55-75.
27. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol; 176: 2-13.
28. Liu B, Bell AW, Paranjpe S, Bowen WC, Khillan JS, Luo JH, Mars WM, Michalopoulos GK. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology 2010; 52: 1060-1067.
29. Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, et al. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009; 175: 717-724.
30. Baena E, Gandarillas A, Vallespinos M, Zanet J, Bachs O, Redondo C, et al. c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Proc Natl Acad Sci U S A 2005; 102: 7286-7291.
31. Mauleon I, Lombard MN, Munoz-Alonso MJ, Canelles M, Leon J. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: differential regulation of mad family and stress-mediated induction of c-myc. Mol Carcinog 2004; 39: 85-90.
32. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431: 1112-1117.